Market revenue in 2020 | USD 19.9 million |
Market revenue in 2028 | USD 54.1 million |
Growth rate | 13.3% (CAGR from 2020 to 2028) |
Largest segment | Lymphoma |
Fastest growing segment | Lymphoma |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Leukemia, Lymphoma, MPNs, Other Cancers |
Key market players worldwide | Roche Holding AG, Abbott Laboratories, Qiagen NV, Danaher Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemato oncology testing market will help companies and investors design strategic landscapes.
Lymphoma was the largest segment with a revenue share of 46.23% in 2020. Horizon Databook has segmented the South Korea hemato oncology testing market based on leukemia, lymphoma, mpns, other cancers covering the revenue growth of each sub-segment from 2018 to 2028.
South Korea hemato oncology testing market is expected to grow at a lucrative rate during the forecast period owing to increase in prevalence of metabolic bone diseases and the country’s aging population. According to the Make Blood Cancer Visible survey conducted by Janssen Asia Pacific in 2018, in South Korea, non-Hodgkin lymphoma and leukemia are the two most common types of blood cancer.
The same source states that the incidence of multiple myeloma has doubled over 10 years in South Korea. Furthermore, according to data published by Globocan, in 2020 around 5,431 new cases of nonHodgkin lymphoma and 3,845 new cases of leukemia were diagnosed in South Korea.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hemato oncology testing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea hemato oncology testing market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account